CBD Global Sciences Inc Ordinary Shares Stock (OTC: CBDNF)

CBD Global Sciences Inc Ordinary Shares (OTC:CBDNF) Stock, Quote.Headers.trade-ideas

Cannabis

News

Markets

CBDNF

CSE:CBDN

Global Sciences&#39; Legacy Distribution Group Acquires Direct Store Distribution Operation From New Age Beverage Corp.

Biotech

Penny Stocks

Success Stories

Startups

Small Business

General

CBD Global Sciences, Inc., dba Global Sciences Inc. (OTCPK:CBDNF) (CSE:CBDN) (Frankfurt:GS3.F) (Munich:GS3.MU) has signed into a binding letter of intent with Pure Vision Technology LLC for the acquisition of 100% of Pure BioPlastics Inc., a company in Ft. Lupton, Colorado.

CBD Global Sciences To Acquire Pure BioPlastics, A Colorado Renewable Plastics Company

CBD Global Sciences, Inc. (OTC: CBDNF) (CSE:CBDN) (Frankfurt:GS3) has begun the process to formally change its name from “CBD Global Sciences” to “Global Sciences Inc.,” dropping CBD from its name.

CBD Global Sciences Begins The Process Of Name Change In Keeping With &#39;Ever-Changing Industry&#39;

CBD Global Sciences Inc Ordinary Shares

Citigroup analyst Ronald Josey maintains Upwork (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) with a Neutral and lowers the price target from $13 to $11.

Price Target

Analyst Ratings

UPWK

Citigroup Maintains Neutral on Upwork, Lowers Price Target to $11

MSFT

OpenAi Says Signed The Core Commitments Of The EU AI Pact

Citigroup analyst Michael Rollins maintains Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) with a Buy and raises the price target from $47 to $49.

Citigroup Maintains Buy on Verizon Communications, Raises Price Target to $49

XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading lower on Wednesday.</a>
In fact, shares of U.S.-listed Chinese companies are trading lower amid a possible selloff following yesterday&#8217;s strength after China&#8217;s <a target="_blank" href="https://www.benzinga.com/government/24/09/41004045/whats-going-on-with-chinese-stocks-alibaba-nio-xpeng-li-auto-on-tuesday" rel="noreferrer noopener">Central Bank announced a new stimulus&nbsp;package.</a>
The stimulus package provides for a cut to the reserve requirement ratio by 0.5 percentage points, drops the loan prime rate and deposit rates by 0.2 to 0.25 percentage points and lowers the <a target="_blank" href="https://www.benzinga.com/news/24/09/41028173/whats-going-on-with-nio-stock-wednesday" rel="noreferrer noopener">seven-day reverse repurchase rate to&nbsp;1.5%</a>.
In addition, the central bank&#8217;s package cuts the minimum down-payment ratio to&nbsp;15%&nbsp;for second time home buyers. The bank announced this plan as a way to combat the slowdown in China&#8217;s markets.
Also Read: <a target="_blank" href="https://cnevpost.com/2024/09/25/xpeng-launches-x9-new-variant/" rel="noreferrer noopener">XPeng Touches Production Milestone Of 500K EVs: Here&#8217;s How Many Electric Cars The Chinese Company Has Delivered</a>
Meanwhile, XPeng has reportedly introduced a new version of its MPV (Multi-Purpose Vehicle), the X9, to broaden its customer base and boost sales.
Today, the Chinese electric vehicle (EV) manufacturer launched the X9 610 Max, starting at RMB 379,800 ($54,090), <a target="_blank" href="https://cnevpost.com/2024/09/25/xpeng-launches-x9-new-variant/" rel="noreferrer noopener">reported</a> CnEV Post.
This new variant is RMB 20,000 pricier than the base X9 610 Pro, but it includes two LiDAR sensors for the XNGP driving feature.
In the first eight months of 2024, XPENG delivered 77,209 Smart EVs, a&nbsp;<a target="_blank" href="https://www.benzinga.com//node/40668056" rel="noreferrer noopener">17%&nbsp;increase from the same period last year.</a>
Monthly deliveries of the X9 have consistently ranged between 1,000 and 2,000 over the past few months, with 1,450 units delivered in August, based on data gathered by CnEVPost.
Price Action: XPEV shares are trading lower by 1.73% to $10.52 at last check Wednesday.
Photo by Koshiro K on Shutterstock
Read More:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40979752/elon-musk-says-buses-wont-be-needed-once-tesla-robotaxis-start-operating-will-take-people-point-" target="_blank" rel="noreferrer noopener">Elon Musk Says Buses Won&#8217;t Be Needed Once Tesla Robotaxis Start Operating: ‘Will Take People Point To Point For A Similar Cost&#8217;</a></li>
</ul>

Equities

Movers

Media

XPEV

What's Going On With Chinese EV Maker XPeng Stock Wednesday?

Citigroup analyst Steven Zaccone maintains AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) with a Buy and lowers the price target from $3787 to $3500.

Citigroup Maintains Buy on AutoZone, Lowers Price Target to $3500

Citigroup analyst Peter Christiansen maintains Sterling Check (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STER#NASDAQ">STER</a>) with a Neutral and raises the price target from $16.2 to $17.5.

STER

Citigroup Maintains Neutral on Sterling Check, Raises Price Target to $17.5

Several Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining stocks are in the spotlight Wednesday amid positive analyst coverage and an uptick across the <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41002643/bitcoin-etfs-see-4-5m-inflow-but-miners-could-actually-cause-the-next-big-move-up#">broader cryptocurrency market</a>.
What To Know: Cipher Mining Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) shares are leading the way Wednesday, up approximately 12% at last check, per <a href="http://pro.benzinga.com">Benzinga Pro</a>. The stock closed Tuesday up 15.1% after the company announced the closing of a <a href="https://www.benzinga.com/pressreleases/24/09/g41003371/cipher-mining-announces-the-closing-of-its-acquisition-of-barber-lake-300-mw-data-center-site" target="_blank" rel="noreferrer noopener">300 MW data center site</a> in West Texas.
Including the Barber Lake site in West Texas and other recently announced purchases, Cipher said its portfolio is now expected to grow to more than 2.5 GW across 10 sites.
Macquarie analyst Paul Golding initiated coverage on Cipher late Tuesday with an Outperform rating and set a price target of&nbsp;$6. The positive analyst initiation appears to be driving some of the upward momentum in the name. Northland Capital Markets analyst Mike Grondahl also initiated coverage on Cipher with an Outperform rating Wednesday morning.
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41022826/bill-maher-slams-bitcoin-mining-nonsense-of-finding-a-number-means-green-energy-progress-i">Bill Maher Slams Bitcoin Mining: &#8216;Nonsense Of Finding A Number&#8217; Means Green Energy Progress Is Being &#8216;Sucked Away By Crypto&#8217;</a>
Several other Bitcoin miners appear to have gotten a lift from positive analyst coverage on Wednesday. Multiple mining stocks jumped in early trading before paring gains. 
CleanSpark Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) was reiterated Buy by HC Wainwright &amp; Co. analysts. The firm maintained a price target of $27 on CleanSpark shares. Macquarie also initiated coverage on CleanSpark Wednesday morning with an Outperform rating and price target of&nbsp;$20. 
Macquarie initiated coverage on Marathon Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) and Riot Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) as well. The firm placed Outperform ratings on both of the Bitcoin mining stocks with price targets of $22 and $15, respectively. 
The broader crypto space is getting a boost on Wednesday, led by Bitcoin, which was up 1.22% over a 24-hour period at the time of writing, hovering around $63,825. Bitcoin spot ETFs saw <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41002643/bitcoin-etfs-see-4-5m-inflow-but-miners-could-actually-cause-the-next-big-move-up#">net inflows of $4.56 million</a>&nbsp;to start the week. 
As reported by Benzinga, crypto analyst Ilia Otychenko sees Bitcoin facing heavy resistance around current levels, but he believes a sustained break above the 200-day moving average could push prices up toward $67,000. Based on historical indicators, Otychenko recently suggested that &#8220;Bitcoin could be on track for a new all-time high in the coming months.&#8221;
$BTC Price Action: At the time of publication, Bitcoin was up about 1.2% over the past 24 hours, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41002643/bitcoin-etfs-see-4-5m-inflow-but-miners-could-actually-cause-the-next-big-move-up#">Bitcoin ETFs See $4.5M Inflow, But Miners Could Actually Cause The Next Big Move Up</a></li>
</ul>
Photo: Benjamin Nelan from Pixabay.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

CIFR

CLSK

MARA

RIOT

Cipher Mining Shares Continue To Climb: What's Going On With Bitcoin Mining Stocks Wednesday?

Citigroup analyst Peter Christiansen maintains Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) with a Neutral and raises the price target from $125 to $145.

PAYX

Citigroup Maintains Neutral on Paychex, Raises Price Target to $145

With earnings season winding down, Chris Ballard, managing director at Check Capital Management, shared his exclusive insights on the companies that have caught his attention for their stellar performance <a href="https://www.benzinga.com/earnings">and growth potential</a>.
Here are his top stock picks based on their latest earnings results:
<h1 class="wp-block-heading">Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)</h1>
Alphabet continues to stand out in Ballard&#8217;s view, delivering impressive growth across key segments. 
&#8220;Search revenues were up 14%, with expanding margins, and YouTube Ads grew 13%, making it the most streamed TV service in the U.S.,&#8221; he noted. 
Google Cloud&#8217;s quarterly revenue milestone of $10 billion also adds to the tech giant's appeal. 
Despite the U.S. government's public scrutiny, Ballard emphasized Alphabet&#8217;s robust cash generation and clean balance sheet, making it a compelling choice for long-term investors.
<h1 class="wp-block-heading">First Citizens BancShares Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>)</h1>
Ballard also highlighted First Citizens BancShares as a notable performer. 
&#8220;It's one of the best banks in the nation, with returns on assets at 1.4% and return on equity at 14.1%,&#8221; he explained. 
What sets First Citizens apart is its ability to achieve these results with less risk, avoiding complex global trading and derivative transactions, noted Ballard. Their simple strategy of taking low-cost deposits and lending to safe borrowers has been the key to their success.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40937291/bank-stocks-hit-inflection-point-after-feds-50-basis-point-cut-analyst-reveal-top-p">Bank Stocks Hit Inflection Point After Fed&#8217;s 50 Basis Point Cut, Analyst Reveals Top Picks</a>
<h1 class="wp-block-heading">AerCap Holdings NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AER#NYSE">AER</a>)</h1>
In the aviation leasing space, Ballard praised AerCap for its strong results and raised guidance. 
&#8220;Gus Kelly's strategy of selling assets at a premium and buying back stock at a discount continues to drive value,&#8221; Ballard noted. AerCap's earnings have surged, boosting their per-share book value by 25% over the past year. Despite a 50% rise in the stock price, Ballard still sees it as attractively valued.
When asked about sector performance and reacting to negative earnings reports like FedEx's, Ballard emphasized a long-term approach. 
"We don't make knee-jerk reactions. If the issues are macroeconomic, we hold our position. FedEx has ambitious cost-cutting initiatives that will likely drive future growth."
For investors looking to capitalize on post-earnings moves, Ballard suggests focusing on companies with strong fundamentals and not being swayed by market noise.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/24/09/41028133/could-visa-rebound-like-alphabet-doj-lawsuit-weighs-on-stock-but-opportunity-looms">Could Visa Rebound Like Alphabet? DOJ Lawsuit Weighs On Stock, But Opportunity Looms</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Hedge Funds

Exclusives

Tech

Trading Ideas

Interview

FCNCA

GOOG

GOOGL

EXCLUSIVE: Alphabet, AerCap, First Citizens: Asset Manager's Trio Of Post-Earnings Bets

Analysts' ratings for Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) over the last quarter vary from bullish to bearish, as provided by 45 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">17</td>
<td style="text-align: right;">19</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $203.09, a high estimate of $240.00, and a low estimate of $170.00. This current average reflects an increase of 0.8% from the previous average price target of $201.48. 
<img src="https://www.benzinga.com/files/images/story/2024/1727287302_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A comprehensive examination of how financial experts perceive Alphabet is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$196.00</td>
<td>$196.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$222.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$200.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$170.00</td>
<td>-</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Neutral</td>
<td>$190.00</td>
<td>-</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Brian Nowak</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$190.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Rohit Kulkarni</td>
<td>Roth MKM</td>
<td>Maintains</td>
<td>Buy</td>
<td>$206.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$222.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Michael Morris</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$205.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Ronald Josey</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$212.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Brad Erickson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$204.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Lloyd Walmsley</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$204.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Rohit Kulkarni</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$206.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$206.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$196.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$208.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$190.00</td>
<td>$187.00</td>
</tr>
<tr>
<td>Brian Nowak</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$205.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Barton Crockett</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$181.00</td>
<td>$181.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Brian Nowak</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$210.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Scott Devitt</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$222.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$206.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Joseph Bonner</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$215.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Shweta Khajuria</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$240.00</td>
<td>-</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$187.00</td>
<td>$168.00</td>
</tr>
<tr>
<td>Alan Gould</td>
<td>Loop Capital</td>
<td>Maintains</td>
<td>Hold</td>
<td>$170.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Barton Crockett</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$181.00</td>
<td>$182.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Alphabet. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Alphabet compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Alphabet's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Alphabet analyst ratings.</a>
<h2>Get to Know Alphabet Better</h2>
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV, YouTube Music among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform, or GCP, accounts for roughly 10% of Alphabet's revenue with the firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) making up the rest.
<h3>Alphabet: Delving into Financials</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Positive Revenue Trend: Examining Alphabet's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.59% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Communication Services sector.
Net Margin: Alphabet's net margin excels beyond industry benchmarks, reaching 27.87%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 7.96%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 5.75%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.09.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

45 Analysts Have This To Say About Alphabet

Ratings for Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $326.38, a high estimate of $381.00, and a low estimate of $215.00. Witnessing a positive shift, the current average has risen by 2.31% from the previous average price target of $319.00.
<img src="https://www.benzinga.com/files/images/story/2024/1727287290_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Amgen. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Skorney</td>
<td>Baird</td>
<td>Maintains</td>
<td>Underperform</td>
<td>$215.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Yaron Weber</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$381.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Jay Olson</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$380.00</td>
<td>$380.00</td>
</tr>
<tr>
<td>James Shin</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$305.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Geoff Meacham</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$330.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Gregory Renza</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$362.00</td>
<td>$332.00</td>
</tr>
<tr>
<td>Mohit Bansal</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$335.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Terence Flynn</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$303.00</td>
<td>$310.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Amgen. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Amgen compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Amgen's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Amgen's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AMGN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Amgen analyst ratings.</a>
<h2>Discovering Amgen: A Closer Look</h2>
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
<h3>Understanding the Numbers: Amgen's Finances</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Amgen's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 20.07%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.
Net Margin: Amgen's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 8.89% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Amgen's ROE excels beyond industry benchmarks, reaching 13.63%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.81%, the company showcases effective utilization of assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 10.57, caution is advised due to increased financial risk.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMGN

Analyst Expectations For Amgen's Future

During the last three months, 7 analysts shared their evaluations of Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $35.71, a high estimate of $40.00, and a low estimate of $28.00. A 4.6% drop is evident in the current average compared to the previous average price target of $37.43. 
<img src="https://www.benzinga.com/files/images/story/2024/1727287279_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Verint Systems. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Shaul Eyal</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$36.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Dan Bergstrom</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$36.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$28.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Peter Levine</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$30.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Joshua Reilly</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Verint Systems. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Verint Systems compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Verint Systems's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Verint Systems's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VRNT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Verint Systems analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Verint Systems Better</h2>
Verint Systems Inc with its subsidiaries helps brands provide Boundless Customer Engagement. The company's solutions help iconic brands close the gap created when it lacks the resources required to deliver experiences that fulfill customer expectations. Geographically, it derives a majority of its revenue from the United States.
<h3>Key Indicators: Verint Systems's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Positive Revenue Trend: Examining Verint Systems's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.0% as of 31 July, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 0.69%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Verint Systems's ROE stands out, surpassing industry averages. With an impressive ROE of 0.18%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Verint Systems's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.07%, the company showcases efficient use of assets and strong financial health.
Debt Management: Verint Systems's debt-to-equity ratio is below the industry average. With a ratio of 0.53, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VRNT

The Analyst Landscape: 7 Takes On Verint Systems

Throughout the last three months, 49 analysts have evaluated Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">22</td>
<td style="text-align: right;">16</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Apple, revealing an average target of $250.8, a high estimate of $300.00, and a low estimate of $186.00. Observing a 6.1% increase, the current average has risen from the previous average price target of $236.38. 
<img src="https://www.benzinga.com/files/images/story/2024/1727287264_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Apple. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pierre Ferragu</td>
<td>New Street Research</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$225.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$260.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$260.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Amit Daryanani</td>
<td>Evercore ISI Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$265.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Matt Farrell</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$225.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Wamsi Mohan</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$256.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Tom Forte</td>
<td>Maxim Group</td>
<td>Maintains</td>
<td>Hold</td>
<td>$203.00</td>
<td>$203.00</td>
</tr>
<tr>
<td>Barton Crockett</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$261.00</td>
<td>$261.00</td>
</tr>
<tr>
<td>Erik Woodring</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$273.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$260.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$285.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Wamsi Mohan</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$256.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>David Vogt</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$236.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Ivan Feinseth</td>
<td>Tigress Financial</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$295.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Maintains</td>
<td>Buy</td>
<td>$255.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Matt Farrell</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$225.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Erik Woodring</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$273.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Amit Daryanani</td>
<td>Evercore ISI Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Wamsi Mohan</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$256.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Benjamin Reitzes</td>
<td>Melius Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$265.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Craig Moffett</td>
<td>MoffettNathanson</td>
<td>Announces</td>
<td>Neutral</td>
<td>$211.00</td>
<td>-</td>
</tr>
<tr>
<td>Erik Woodring</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$273.00</td>
<td>$273.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$260.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Tom Forte</td>
<td>Maxim Group</td>
<td>Raises</td>
<td>Hold</td>
<td>$203.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Barton Crockett</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$261.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$285.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Rod Hall</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$275.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$255.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$186.00</td>
<td>$187.00</td>
</tr>
<tr>
<td>Krish Sankar</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$250.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Srini Pajjuri</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>William Power</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$240.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$187.00</td>
<td>$164.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$265.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Rod Hall</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$265.00</td>
<td>$238.00</td>
</tr>
<tr>
<td>Angelo Zino</td>
<td>CFRA</td>
<td>Raises</td>
<td>Buy</td>
<td>$260.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Ananda Baruah</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$300.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Erik Woodring</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$273.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$275.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Wamsi Mohan</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$256.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$260.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Wamsi Mohan</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$230.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Matt Farrell</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$225.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>David Vogt</td>
<td>UBS</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$220.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Martin Yang</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Apple. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Apple compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Apple's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Apple's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AAPL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Apple analyst ratings.</a>
<h2>Get to Know Apple Better</h2>
Apple is among the largest companies in the world, with a broad portfolio of hardware and software products targeted at consumers and businesses. Apple's iPhone makes up a majority of the firm sales, and Apple's other products like Mac, iPad, and Watch are designed around the iPhone as the focal point of an expansive software ecosystem. Apple has progressively worked to add new applications, like streaming video, subscription bundles, and augmented reality. The firm designs its own software and semiconductors while working with subcontractors like Foxconn and TSMC to build its products and chips. Slightly less than half of Apple's sales come directly through its flagship stores, with a majority of sales coming indirectly through partnerships and distribution.
<h3>Apple: Delving into Financials</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Apple's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 4.87%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Apple's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 25.0%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Apple's ROE excels beyond industry benchmarks, reaching 30.44%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Apple's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 6.41% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Apple's debt-to-equity ratio stands notably higher than the industry average, reaching 1.52. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

The Analyst Landscape: 49 Takes On Apple

In the current market session, Vipshop Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) share price is at $13.85, after a 4.09% decrease. Over the past month, the stock increased by 13.78%, but over the past year, it actually fell by 12.37%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2024/1727287234_0.png" alt="Past Year Chart" />

<h3>Vipshop Holdings P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 26.43 in the Broadline Retail industry, Vipshop Holdings Inc. has a lower P/E ratio of 6.7. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1727287234_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

VIPS

Price Over Earnings Overview: Vipshop Holdings

Citigroup analyst Peter Christiansen maintains First Advantage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FA#NASDAQ">FA</a>) with a Neutral and raises the price target from $19 to $21.

Citigroup Maintains Neutral on First Advantage, Raises Price Target to $21

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) has outperformed the market over the past 5 years by 5.55% on an annualized basis producing an average annual return of 19.74%. Currently, Morgan Stanley has a market capitalization of $164.78 billion. 
Buying $1000 In MS: If an investor had bought $1000 of MS stock 5 years ago, it would be worth $2,386.92 today based on a price of $101.85 for MS at the time of writing.
<h3>Morgan Stanley's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727287230_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today

McKesson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCK#NYSE">MCK</a>) has outperformed the market over the past 15 years by 3.02% on an annualized basis producing an average annual return of 15.04%. Currently, McKesson has a market capitalization of $61.95 billion. 
Buying $1000 In MCK: If an investor had bought $1000 of MCK stock 15 years ago, it would be worth $8,020.07 today based on a price of $477.60 for MCK at the time of writing.
<h3>McKesson's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727287225_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning McKesson Stock In The Last 15 Years

The New York State Office of Cannabis Management (OCM) has introduced the Legal Online Cannabis Activities Locator (LOCAL), a new mapping tool aimed at simplifying the cannabis licensing process <a href="https://www.benzinga.com/topic/new-york-cannabis">across the state.</a>
By leveraging data from the Cannabis Licensing System (CLS), LOCAL makes it easier for businesses to navigate the complexities of compliance, eliminating the need for costly third-party surveys, FingerLakes Daily News <a href="https://www.fingerlakesdailynews.com/regional-state-congressional/ny-unveils-legal-online-cannabis-activities-locator-map">reported.</a>
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/39694320/licensed-but-closed-new-yorks-cannabis-dream-faces-bureaucratic-nightmare">Licensed But Closed: New York&#8217;s Cannabis Dream Faces Bureaucratic Nightmare</a>
Prior to LOCAL's launch, cannabis license applicants had to rely on professional surveying services to meet regulatory requirements—a process that was both expensive and time-consuming. 
The arrival of LOCAL marks a significant shift in this procedure, offering a cost-free, transparent tool that applicants and businesses can use independently.
"LOCAL is a paradigm shift for New York's cannabis industry, providing both businesses and stakeholders with the resources they need to successfully navigate the rapidly growing market," said Felicia A.B. Reid, acting executive director of OCM. "This application reflects OCM's commitment to transparency and to action based on listening to the needs of the market."
<h3 class="wp-block-heading">Key Features Of The LOCAL Map</h3>
LOCAL consists of two main components, designed to serve both industry professionals and consumers.
<ol>
<li>Industry-Focused Map: This is a powerful tool for applicants, licensees and stakeholders, offering features such as proximity reports, license searches, data exports, and layered data navigation. It allows businesses to make informed decisions regarding compliance and location requirements, reducing reliance on third-party services.</li>
<li>Consumer-Focused Dispensary Map: Expected to launch in the coming weeks, this feature will allow New Yorkers to locate the nearest legal dispensary with ease. By providing access to safe, regulated cannabis products, it aims to further bolster the state's legal cannabis market.</li>
</ol>
<h3 class="wp-block-heading">LOCAL: Supporting Growth In The Cannabis Industry</h3>
The OCM's rollout of the LOCAL map is part of a broader effort to support the growing cannabis industry in New York. As of now, there are 197 licensed adult-use dispensaries operating across the state. By making the licensing process more accessible and affordable, the state aims to encourage the growth of more cannabis businesses, while ensuring compliance with New York's regulations.
This tool also aligns with OCM's commitment to listening to stakeholder feedback, making it a critical resource for applicants across the cannabis supply chain. 
"The LOCAL map is not just about efficiency—it's about responding to the real-world needs of those involved in the cannabis industry," Reid concluded.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/03/37897047/exclusive-new-yorks-cannabis-licensing-under-scrutiny-experts-weigh-in">EXCLUSIVE: New York&#8217;s Cannabis Licensing Under Scrutiny: Experts Weigh In</a></li>
</ul>

Regulations

Retail Sales

Legal

Cannabis Licensing And Finding Dispensaries In New York Just Got Easier—Here's How

Citigroup analyst Peter Christiansen maintains Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) with a Neutral and raises the price target from $260 to $295.

Citigroup Maintains Neutral on Automatic Data Processing, Raises Price Target to $295

Donaldson Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dci#NYSE">DCI</a>) recently unveiled its filtration services in France, Germany and Austria. The company plans to expand its presence in the food and beverage markets through this move.
Donaldson&#39;s filtration services will help manufacturers operate their filtration system, providing on-site help and customized solutions to achieve their sustainability, efficiency and effectiveness goals. DCI&#39;s services include testing the integrity of sterile air and liquid filters, calibrating equipment, measuring compressed air quality and managing filters through exchange, maintenance and setup.
With the launch of filtration services for food and beverage in France, Germany and Austria, DCI&#39;s customers will benefit from service teams that work closely with its network of more than 1,000 engineers, scientists and specialists worldwide. The new filtration services for the Life Sciences sector are based on a century of dependable service. The company had been planning to expand into the food and beverage markets in France, Germany and Austria, with goals for growth across Europe.
<h2>DCI&#39;s Zacks Rank and Price Performance</h2>
DCI currently carries a Zacks Rank #4 (Sell). In the year-to-date period, the company&#39;s shares have gained 11.1% compared with the industry&#39;s 25.3% growth.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/81/79027.jpg?v=1736680807" />
Image Source: Zacks Investment Research
Donaldson has been witnessing weakness in the on-road and off-road businesses. Lower levels of equipment production owing to softness in industrial markets, particularly in the United States and China, are affecting the on-road business. Weakness in agriculture markets and soft end-market demand in China have been impacting the off-road business. Also, challenged market conditions in dust collection and power generation verticals within the industrial filtration solutions business remain concerning.
<h2>Stocks to Consider</h2>
Some better-ranked companies are discussed below.
Tetra Tech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttek#NASDAQ">TTEK</a>) presently carries a Zacks Rank #2 (Buy).
The company delivered a trailing four-quarter average earnings surprise of 9.5%. In the past 60 days, the Zacks Consensus Estimate for TTEK&#39;s fiscal 2024 earnings has increased 0.8%.
Atmus Filtration Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atmu#NYSE">ATMU</a>) currently carries a Zacks Rank of 2. ATMU delivered a trailing four-quarter average earnings surprise of 13.4%.
In the past 60 days, the consensus estimate for Atmus&#39; 2024 earnings has increased 3.1%.
Parker-Hannifin Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ph#NYSE">PH</a>) currently carries a Zacks Rank of 2. PH delivered a trailing four-quarter average earnings surprise of 2.6%.
In the past 60 days, the consensus estimate for Parker-Hannifin&#39;s fiscal 2025 earnings has increased 1.3%.
<a href="https://www.zacks.com/stock/news/2340748/donaldson-introduces-filtration-services-for-life-sciences?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2340748">To read this article on Zacks.com click here.</a>

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

CBD Global Sciences Inc Ordinary Shares

CBD Global Sciences Inc Ordinary Shares (CBDNF) Forecast

CBD Global Sciences Inc Ordinary Shares (OTC:CBDNF) Stock, Quote.Headers.trade-ideas